Extract

The primary objective of the study is to evaluate the efficacy of atorvastatin 80 mg daily as compared to atorvastatin 10 mg daily in reducing C-reactive protein levels over a 26-week treatment period in subjects with documented coronary artery disease.

Inclusion criteria

• Coronary Arteriosclerosis ,Hypercholesterolemia

Country

• Canada
• Czech Republic
• France
• Poland
• Romania
• Russian Federation
• Slovakia

Links

• nct
• ictrp